Detalhe da pesquisa
1.
Immunogenicity and safety of BPZE1, an intranasal live attenuated pertussis vaccine, versus tetanus-diphtheria-acellular pertussis vaccine: a randomised, double-blind, phase 2b trial.
Lancet;
401(10379): 843-855, 2023 03 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36906345
2.
Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial.
PLoS Med;
17(3): e1003024, 2020 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32181756
3.
Characterization of drug-resistant influenza virus A(H1N1) and A(H3N2) variants selected in vitro with laninamivir.
Antimicrob Agents Chemother;
58(9): 5220-8, 2014 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24957832
4.
A zanamivir dimer with prophylactic and enhanced therapeutic activity against influenza viruses.
J Antimicrob Chemother;
69(8): 2164-74, 2014 Aug.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24777908
5.
Derivatives of imidazotriazine and pyrrolotriazine C-nucleosides as potential new anti-HCV agents.
Bioorg Med Chem Lett;
24(21): 4984-8, 2014 Nov 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25288185
6.
Validation of a severe acute respiratory syndrome coronavirus 2 microneutralization assay for evaluation of vaccine immunogenicity.
J Virol Methods;
327: 114945, 2024 Jun.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38649070
7.
Safety and Immunogenicity of SARS-CoV-2 Recombinant Spike Protein Vaccine in Children and Adolescents in India: A Phase 2-3 Randomized Clinical Trial.
JAMA Pediatr;
2023 Jul 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37523166
8.
A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults.
Sci Rep;
13(1): 16579, 2023 10 03.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37789040
9.
Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study.
Lancet Reg Health Southeast Asia;
10: 100139, 2023 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36647543
10.
Efficacy and safety of a universal influenza A vaccine (MVA-NP+M1) in adults when given after seasonal quadrivalent influenza vaccine immunisation (FLU009): a phase 2b, randomised, double-blind trial.
Lancet Infect Dis;
22(6): 857-866, 2022 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35305317
11.
Validation of a single-step, single-tube reverse transcription loop-mediated isothermal amplification assay for rapid detection of SARS-CoV-2 RNA.
J Med Microbiol;
69(9): 1169-1178, 2020 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32755529
12.
Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™).
Vaccine;
36(26): 3779-3788, 2018 06 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29779922
13.
CRM1-dependent nuclear export of dengue virus type 2 NS5.
Novartis Found Symp;
277: 149-61; discussion 161-3, 251-3, 2006.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17319160
14.
Discovery and Synthesis of C-Nucleosides as Potential New Anti-HCV Agents.
ACS Med Chem Lett;
5(6): 679-84, 2014 Jun 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24944743
15.
CRM1-mediated nuclear export of dengue virus RNA polymerase NS5 modulates interleukin-8 induction and virus production.
J Biol Chem;
284(23): 15589-97, 2009 Jun 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-19297323
16.
The biarsenical dye Lumio exhibits a reduced ability to specifically detect tetracysteine-containing proteins within live cells.
J Fluoresc;
17(6): 593-7, 2007 Nov.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17805945
17.
Nuclear localization of dengue virus nonstructural protein 5 through its importin alpha/beta-recognized nuclear localization sequences is integral to viral infection.
Traffic;
8(7): 795-807, 2007 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17537211
18.
Dengue virus RNA polymerase NS5: a potential therapeutic target?
Curr Drug Targets;
7(12): 1623-38, 2006 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-17168837
19.
Functional analysis and annotation of the virulence plasmid pMUM001 from Mycobacterium ulcerans.
Microbiology (Reading);
151(Pt 3): 683-692, 2005 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15758215
20.
Common evolutionary origin for the unstable virulence plasmid pMUM found in geographically diverse strains of Mycobacterium ulcerans.
J Bacteriol;
187(5): 1668-76, 2005 Mar.
Artigo
em Inglês
| MEDLINE
| ID: mdl-15716437